Cargando…

Efficacy of anti-pseudomonal antibiotics: Need to reconsider the empirical use of cefepime

Detalles Bibliográficos
Autores principales:	Kotwal, A., Biswas, D., Kakati, B., Thakuria, B., Bhardwaj, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277145/ https://www.ncbi.nlm.nih.gov/pubmed/25488453

Ejemplares similares

Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
por: Shiroshita, Akihiro, et al.
Publicado: (2021)

Empiric Usage of “Anti-Pseudomonal” Agents for Hospital-Acquired Urinary Tract Infections
por: Rahat, Ori, et al.
Publicado: (2022)

De-Escalating Anti-Pseudomonal β-Lactams
por: Catteeuw, J, et al.
Publicado: (2015)

Association Between Empirical Anti-Pseudomonal Antibiotics for Recurrent Lower Respiratory Tract Infections and Mortality: A Retrospective Cohort Study
por: Shiroshita, Akihiro, et al.
Publicado: (2022)

Effect of iron chelation on anti-pseudomonal activity of doxycycline
por: Faure, ME, et al.
Publicado: (2021)

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis
por: Deschamp, Ashley R, et al.
Publicado: (2017)

Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients
por: Côté, Jean-Maxime, et al.
Publicado: (2022)

1881. Empiric Pseudomonal Monotherapy vs. Combination Therapy for Community-Onset Pneumonia in Older Adults
por: Obodozie-Ofoegbu, Obiageri, et al.
Publicado: (2018)

239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)

Reconsidering the COVID-19 vaccine strategy in West and Central Africa
por: Msellati, Philippe, et al.
Publicado: (2022)

Rapid Identification of Gram-Negative Bacteremia and Impact on Anti-Pseudomonal Antibiotic Consumption in Combination with Antibiotic Stewardship at a Community-Based Hospital System
por: Box, Maggie, et al.
Publicado: (2017)

Cloudy dialysate—reconsidering initial empiric therapy
por: Meyrier, A., et al.
Publicado: (2011)

The new Surviving Sepsis Campaign recommendations on glucose control should be reconsidered
por: Schultz, Marcus J., et al.
Publicado: (2008)

A compelling need to empirically validate bipolar depression
por: Martino, Diego J., et al.
Publicado: (2023)

Pseudomonal Diabetic Foot Infections: Vive la Différence?
por: Uçkay, Ilker, et al.
Publicado: (2022)

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?
por: Lodise, Thomas P., et al.
Publicado: (2021)

Effect of Glycyrrhizin on Pseudomonal Skin Infections in Human-Mouse Chimeras
por: Yoshida, Shohei, et al.
Publicado: (2014)

The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Andreatos, Nikolaos, et al.
Publicado: (2017)

1594. Evaluating Clinical Outcomes of an Alternative Cefepime Dosing Regimen as Empiric Antibiotic Therapy in Hospitalized Adults with Febrile Neutropenia
por: Haiduc, Manuela, et al.
Publicado: (2018)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

P081: Cefepime-tazobactam: a new antibiotic against ESBL producing enterobacteriaceae in cancer patients
por: Biswas, S, et al.
Publicado: (2013)

Nephrotoxicity of cefepime: A new cephalosporin antibiotic in rats
por: Elsayed, Mossad Gamaleddin Ahmed, et al.
Publicado: (2014)

Regional anesthesia during the COVID-19 pandemic: a time to reconsider practices? (Letter #1)
por: Soberón, José R., et al.
Publicado: (2020)

Regional anesthesia during the COVID-19 pandemic: a time to reconsider practices? (Letter #2)
por: Aliste, Julian, et al.
Publicado: (2020)

Provider/patient conflict: is it time to reconsider the contraindication for videolaryngoscope use in a bleeding/soiled airway?
por: Turkstra, Timothy P., et al.
Publicado: (2021)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching
por: Baek, Moon Seong, et al.
Publicado: (2023)

Reconsidering inherent requirements: a contribution to the debate from the clinical placement experience of a physiotherapy student with vision impairment
por: Johnston, Kylie N., et al.
Publicado: (2016)

80. Pharmacoeconomic Analysis Comparing the Empiric Utilization of Cefepime Versus Piperacillin/tazobactam
por: Olmack, Kelsey, et al.
Publicado: (2020)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity
por: Degasperi, Margherita, et al.
Publicado: (2020)

In reply: Regional anesthesia during the COVID-19 pandemic: a time to reconsider practices? (Letters #1 and #2)
por: Lie, Sui An, et al.
Publicado: (2020)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

2687. Extended Infusions of Piperacillin/Tazobactam vs. Cefepime for Empiric Treatment of Neutropenic Fever
por: Norman, Sarah, et al.
Publicado: (2019)

Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021)

Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in Penicillin Allergic Patients
por: Caplinger, Christina, et al.
Publicado: (2016)

The Ecology of Antibiotic Use in the ICU: Homogeneous Prescribing of Cefepime but Not Tazocin Selects for Antibiotic Resistant Infection
por: Ginn, Andrew N., et al.
Publicado: (2012)

Cefepime-Resistant Pseudomonas aeruginosa
por: Akhabue, Ehimare, et al.
Publicado: (2011)

1883. Acute Kidney Injury in Patients With Pneumonia on Concomitant Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonal β-Lactam Therapy
por: Raux, Brian R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1jjq1th5u87e6rtrbag7ckns6p